ADC THERAPEUTICS SA's ticker is ADCT and the CUSIP is H0036K147. A total of 53 filers reported holding ADC THERAPEUTICS SA in Q1 2022. The put-call ratio across all filers is 0.38 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $40,394 | -20.4% | 18,788 | -27.8% | 0.00% | – |
Q1 2023 | $50,755 | -5.3% | 26,028 | +86.4% | 0.00% | – |
Q4 2022 | $53,618 | -76.5% | 13,963 | -70.6% | 0.00% | – |
Q3 2022 | $228,000 | +34.9% | 47,422 | +312.4% | 0.00% | – |
Q1 2022 | $169,000 | -97.3% | 11,500 | -96.3% | 0.00% | – |
Q4 2021 | $6,210,000 | +164.4% | 307,532 | +255.5% | 0.00% | – |
Q3 2021 | $2,349,000 | -2.9% | 86,500 | -12.9% | 0.00% | – |
Q2 2021 | $2,418,000 | -46.2% | 99,324 | -46.0% | 0.00% | – |
Q1 2021 | $4,494,000 | +153.6% | 184,088 | +232.4% | 0.00% | – |
Q4 2020 | $1,772,000 | +427.4% | 55,388 | +443.0% | 0.00% | – |
Q3 2020 | $336,000 | – | 10,200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vantage Consulting Group Inc | 1,680,149 | $33,939,000 | 9.12% |
Redmile Group, LLC | 7,451,029 | $150,511,000 | 3.42% |
Grosvenor Holdings, L.L.C. | 1,517,212 | $30,648,000 | 3.17% |
Indie Asset Partners, LLC | 96,582 | $1,951,000 | 1.42% |
MPM BioImpact LLC | 337,396 | $6,815,000 | 1.24% |
Eventide Asset Management | 1,975,000 | $39,895,000 | 0.51% |
HHLR ADVISORS, LTD. | 500,000 | $10,100,000 | 0.16% |
Virtus ETF Advisers LLC | 19,193 | $388,000 | 0.15% |
CNA FINANCIAL CORP | 15,245 | $308,000 | 0.08% |
Employees Retirement System of Texas | 278,000 | $5,616,000 | 0.06% |